Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,061.60
+27.00 (2.61%)
At close: Jun 3, 2025, 3:30 PM IST
Alivus Life Sciences Revenue
In the fiscal year ending March 31, 2025, Alivus Life Sciences had annual revenue of 23.87B INR with 4.54% growth. Alivus Life Sciences had revenue of 6.50B in the quarter ending March 31, 2025, with 21.05% growth.
Revenue
23.87B
Revenue Growth
+4.54%
P/S Ratio
5.32
Revenue / Employee
11.85M
Employees
2,014
Market Cap
126.87B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |